American Pharmaceutical Partners Inc., a generic drug manufacturer that recently moved its headquarters to Illinois from Los Angeles, has announced positive results for a long-awaited trial of its proprietary breast cancer drug ABI-007, now called Abraxane. The news sent the stock up $4 a share last week to $43, more than four times higher than its 52-week low of $10.05 …